- Home
- OM
as 07-08-2024 4:00pm EST
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 185.4M | IPO Year: | 2020 |
| Target Price: | $5.30 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.92 - $20.96 | Next Earning Date: | 07-31-2024 |
| Revenue: | $125,077,000 | Revenue Growth: | 5.74% |
| Revenue Growth (this year): | 15.67% | Revenue Growth (next year): | 18.60% |
Stock Insider Trading Activity of Outset Medical Inc. (OM)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Brottem John L. | OM | General Counsel | Jun 12 '24 | Sell | $4.78 | 10,569 | $50,519.82 | 233,306 | SEC Form 4 |
| GROSSMAN D KEITH | OM | Director | Jun 3 '24 | Sell | $3.80 | 26,230 | $99,765.81 | 47,805 | SEC Form 4 |
| GROSSMAN D KEITH | OM | Director | Jun 3 '24 | Sell | $3.74 | 11,887 | $44,468.08 | 74,035 | SEC Form 4 |
| Trigg Leslie | OM | Chair and CEO | May 16 '24 | Sell | $3.53 | 5,237 | $18,486.61 | 915,804 | SEC Form 4 |
| Ahmed Nabeel | OM | Chief Financial Officer | May 16 '24 | Sell | $3.53 | 3,918 | $13,830.54 | 318,959 | SEC Form 4 |
| Nash Marc | OM | SVP Operations and R&D | May 16 '24 | Sell | $3.53 | 1,097 | $3,872.41 | 241,413 | SEC Form 4 |
| Racine Jean-Olivier | OM | Chief Technology Officer | May 10 '24 | Sell | $3.27 | 8,306 | $27,160.62 | 265,325 | SEC Form 4 |
| Nash Marc | OM | SVP Operations and R&D | Mar 15 '24 | Sell | $2.13 | 2,391 | $5,092.83 | 242,510 | SEC Form 4 |
| Ahmed Nabeel | OM | Chief Financial Officer | Feb 29 '24 | Sell | $3.15 | 1,584 | $4,989.60 | 322,877 | SEC Form 4 |
| Trigg Leslie | OM | Chair and CEO | Feb 15 '24 | Sell | $3.57 | 5,320 | $18,992.40 | 833,091 | SEC Form 4 |
| Brottem John L. | OM | General Counsel | Feb 15 '24 | Sell | $3.57 | 3,341 | $11,927.37 | 245,046 | SEC Form 4 |
| Racine Jean-Olivier | OM | Chief Technology Officer | Feb 15 '24 | Sell | $3.57 | 1,866 | $6,661.62 | 271,830 | SEC Form 4 |
| Nash Marc | OM | SVP Operations and R&D | Feb 15 '24 | Sell | $3.57 | 617 | $2,202.69 | 243,100 | SEC Form 4 |
| Ahmed Nabeel | OM | Chief Financial Officer | Feb 15 '24 | Sell | $3.57 | 4,403 | $15,718.71 | 312,594 | SEC Form 4 |
| Williamson Steven S. | OM | Chief Commercial Officer | Feb 15 '24 | Sell | $3.57 | 2,500 | $8,925.00 | 320,347 | SEC Form 4 |
| Porter Stacey L. | OM | Chief People Officer | Jan 12 '24 | Sell | $4.29 | 768 | $3,294.72 | 61,448 | SEC Form 4 |
| Ahmed Nabeel | OM | Chief Financial Officer | Jan 12 '24 | Sell | $4.29 | 1,726 | $7,404.54 | 316,997 | SEC Form 4 |
| Williamson Steven S. | OM | Chief Commercial Officer | Jan 12 '24 | Sell | $4.29 | 996 | $4,272.84 | 322,847 | SEC Form 4 |
| Trigg Leslie | OM | Chair and CEO | Jan 12 '24 | Sell | $4.29 | 8,126 | $34,860.54 | 838,411 | SEC Form 4 |
| Racine Jean-Olivier | OM | Chief Technology Officer | Jan 12 '24 | Sell | $4.29 | 723 | $3,101.67 | 273,696 | SEC Form 4 |
| Williamson Steven S. | OM | Chief Commercial Officer | Jan 8 '24 | Sell | $5.49 | 7,055 | $38,731.95 | 105,939 | SEC Form 4 |
| Trigg Leslie | OM | Chair and CEO | Jan 8 '24 | Sell | $5.49 | 14,188 | $77,892.12 | 389,099 | SEC Form 4 |
| Porter Stacey L. | OM | Chief People Officer | Jan 8 '24 | Sell | $5.49 | 4,766 | $26,165.34 | 58,630 | SEC Form 4 |
| Ahmed Nabeel | OM | Chief Financial Officer | Jan 8 '24 | Sell | $5.49 | 10,709 | $58,792.41 | 76,819 | SEC Form 4 |
| Brottem John L. | OM | General Counsel | Jan 8 '24 | Sell | $5.49 | 7,344 | $40,318.56 | 48,807 | SEC Form 4 |
Latest Outset Medical Inc. News
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
Zacks
a month ago
Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock?
GOBankingRates
a month ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
a month ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
a month ago
Italy beat Bosnia in final Euros warm-up
Bloomberg
a month ago
Macron Calls French Legislative Election After Far-Right Surge
AFP
a month ago
Trump loyalists proud to support 'felon' at Las Vegas rally
Business Insider
a month ago
US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
Insider Monkey
a month ago
The Best Woody Perfume For Women
Share on Social Networks:
Disclaimer
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.